Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

NCT07321067 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Ahmed Karam Helmy